A Possible Solution To Europe's Pharma Financing Problem

Law360, New York (July 10, 2015, 10:18 AM EDT) -- Recession and consequent cuts in public pharmaceutical expenditure in Europe have slowed down the access to market of pharmaceutical innovations in the last few years. As a solution, public health authorities and pharmaceutical companies have searched for alternative funding formulas, in order to share the risks and uncertainties arising from public coverage of new medicinal products, whose clinical effectiveness and budgetary impact are still unknown....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!